Multi-Target Stool RNA Test for CRC Screening: When Should You Use It? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus),…
Multi-Target Stool RNA Test for CRC Screening: When Should You Use It?
Posted on June 18, 2024
Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?
Posted on
Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding? Jeffrey Lee, MD, MPH Research Scientist and…
When to Discontinue Colon Polyp Surveillance in Older Adults?
Posted on
When to Discontinue Colon Polyp Surveillance in Older Adults? Timothy Yen, MD Assistant Professor of Medicine, Division of Gastroenterology, Loma…
ICYMI: Budesonide Oral Suspension Improves Outcomes in Eosinophilic Esophagitis
Posted on May 14, 2024
Swathi Eluri, MD, MSCR takes an evidence-based look at a 2022 article which showed budesonide oral suspension improved outcomes in patients with EoE.
Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version?
Posted on
Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief…
Linaclotide Effective for Functional Constipation in 6-17 Year Olds: First FDA-Approved Constipation Treatment for Children
Posted on
Linaclotide Effective for Functional Constipation in 6-17 Year Olds: First FDA-Approved Constipation Treatment for Children Ahmad Abu-Heija, MBBS Consultant Gastroenterologist,…
PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment?
Posted on
PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment? Bharati Kochar, MD, MS Assistant Professor of Medicine, Division of…
Cell-free DNA Blood Test for CRC Screening: A Promising Development but Won’t “Eclipse” Current Tools
Posted on April 23, 2024
Cell-free DNA Blood Test for CRC Screening: A Promising Development Won’t “Eclipse” Current Tools Philip Schoenfeld, MD, MSEd, MSc (Epi)…
First FDA-Approved NASH Treatment Produces NASH Resolution and Decreases Fibrosis: Results from the MAESTRO-NASH Trial
Posted on
First FDA-Approved NASH Treatment Produces NASH Resolution and Decreases Fibrosis: Results From the Landmark Phase 3 MAESTRO-NASH Trial Phillip Leff,…
How Effective Are Obesity Medications for Reducing Hepatic Decompensation in NASH?
Posted on
How Effective are Obesity Medications for Reducing Hepatic Decompensation in MASH? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology…